Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Non-Current Deferred Tax Liability (2019 - 2021)

SELLAS Life Sciences (SLS) has disclosed Non-Current Deferred Tax Liability for 3 consecutive years, with $239000.0 as the latest value for Q3 2021.

  • Quarterly Non-Current Deferred Tax Liability fell 8.78% to $239000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $239000.0 through Sep 2021, down 8.78% year-over-year, with the annual reading at $1.4 million for FY2020, 428.63% up from the prior year.
  • Non-Current Deferred Tax Liability for Q3 2021 was $239000.0 at SELLAS Life Sciences, roughly flat from $239000.0 in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $1.4 million in Q4 2020, with the low at $239000.0 in Q1 2021.
  • Average Non-Current Deferred Tax Liability over 3 years is $383727.3, with a median of $262000.0 recorded in 2019.
  • Peak annual rise in Non-Current Deferred Tax Liability hit 428.63% in 2020, while the deepest fall reached 26.61% in 2020.
  • Over 3 years, Non-Current Deferred Tax Liability stood at $262000.0 in 2019, then skyrocketed by 428.63% to $1.4 million in 2020, then plummeted by 82.74% to $239000.0 in 2021.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $239000.0, $239000.0, and $239000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.